Skip to content
healthcare.dev

Gabapentin

NDC 87063-686, Gabapentin, capsule, from ASCLEMED USA INC..

Product NDC
87063-686
Status
Listed
Labeler
ASCLEMED USA INC.
Dosage form
CAPSULE
Route
ORAL
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
ANDA
Application
ANDA090858
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/87063-686 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • GABAPENTIN400 mg/1

Pharmacologic classes

Decreased Central Nervous System Disorganized Electrical Activity [PE]

Package NDCNDC-11Package
87063-686-1287063068612120 CAPSULE in 1 BOTTLE (87063-686-12)
87063-686-308706306863030 CAPSULE in 1 BOTTLE (87063-686-30)
87063-686-608706306866060 CAPSULE in 1 BOTTLE (87063-686-60)
87063-686-908706306869090 CAPSULE in 1 BOTTLE (87063-686-90)

Linked data

RxNorm, label and prices

RxNorm concepts

RxNorm links no concept to this product's packages.

Related lookups

No FDA label, Medicare Part B payment limit or NADAC price is linked to this product.

Use it

Look up 87063-686 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/87063-686 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 87063-686. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.